Middle East Tech Today
SEE OTHER BRANDS

The best science and technology news from the Middle East

Middle East Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.

Press releases published on April 3, 2025

MoonLake Secures up to $500 Million in Non-Dilutive Financing from Hercules Capital and Announces a Capital Markets Update on April 29 to Provide Important Clinical Updates

MoonLake Secures up to $500 Million in Non-Dilutive Financing from Hercules Capital and Announces a Capital Markets Update on April 29 to Provide Important Clinical Updates

Agreement with Hercules Capital significantly increases financial and operational strength, provides up to $500 million in capital with no dilution to shareholders, an attractive cost of capital and low operational and strategic incumbrances, and sets a …

Boundless Bio to Participate in the Needham Virtual Healthcare Conference

Boundless Bio to Participate in the Needham Virtual Healthcare Conference

SAN DIEGO, April 03, 2025 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified …

Auron Presents New Preclinical Data for AUTX-703 in Small Cell Lung Cancer (SCLC)

Auron Presents New Preclinical Data for AUTX-703 in Small Cell Lung Cancer (SCLC)

NEWTON, Mass., April 03, 2025 (GLOBE NEWSWIRE) -- Auron Therapeutics,  a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease, today announced data from a poster presentation …

Axonius Appoints David Walters as Chief Revenue Officer

Axonius Appoints David Walters as Chief Revenue Officer

NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Axonius, the leader in cyber asset management that delivers visibility and actionability across all digital assets, today announced the appointment of David Walters as Chief Revenue Officer (CRO). Walters brings …

Lianhe Sowell International Group Ltd Announces Pricing of Initial Public Offering

Lianhe Sowell International Group Ltd Announces Pricing of Initial Public Offering

Shenzhen, China, April 03, 2025 (GLOBE NEWSWIRE) -- Lianhe Sowell International Group Ltd (the “Company”), a provider of machine vision products and solutions applied in a wide range of businesses across industries in China, today announced the pricing of …

Breaking News: Early Clinical Trial on Plant-Based Finasteride Alternative Shows Exciting Results Amid Growing Concerns Over Drug Side Effects

Breaking News: Early Clinical Trial on Plant-Based Finasteride Alternative Shows Exciting Results Amid Growing Concerns Over Drug Side Effects

CLEVELAND, April 03, 2025 (GLOBE NEWSWIRE) -- The hair loss industry is at a tipping point. A recent Wall Street Journal exposé has reignited concerns about the severe and long-term side effects of finasteride, the FDA-approved drug for male pattern …

Lane One Transport Automates Carrier Communication and Qualification with Integrated Parade and Descartes Solutions

Lane One Transport Automates Carrier Communication and Qualification with Integrated Parade and Descartes Solutions

ATLANTA, April 03, 2025 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that Texas-based Lane One Transport, a leader in freight brokerage, is …

GFG Announces C$2.5 Million Flow-Through Private Placement

GFG Announces C$2.5 Million Flow-Through Private Placement

SASKATOON, Saskatchewan, April 03, 2025 (GLOBE NEWSWIRE) -- GFG Resources Inc. (TSXV: GFG) (OTCQB: GFGSF) (“GFG” or the “Company”) announces a private placement of premium flow-through units ("Premium Units") to raise gross proceeds of up to C$2.5 million …

Unlock the Future of Cybersecurity at the OpenSSL Conference 2025 in Prague

Unlock the Future of Cybersecurity at the OpenSSL Conference 2025 in Prague

NEWARK, Del., April 03, 2025 (GLOBE NEWSWIRE) -- The OpenSSL Corporation and the OpenSSL Foundation are proud to announce the OpenSSL Conference 2025, taking place from October 7 to 9, 2025, in Prague, Czech Republic, at the Vienna House by Wyndham …

Sai Life Sciences sets up Peptide Research Center in India

Sai Life Sciences sets up Peptide Research Center in India

HYDERABAD, India, April 03, 2025 (GLOBE NEWSWIRE) -- Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), has inaugurated a dedicated Peptide Research Center at …

Solo.io Announces MCP Gateway to Simplify and Secure AI Agent Development in Kubernetes

Solo.io Announces MCP Gateway to Simplify and Secure AI Agent Development in Kubernetes

LONDON, April 03, 2025 (GLOBE NEWSWIRE) -- KubeCon + CloudNativeCon Europe 2025 -- Solo.io, the leading cloud native application networking company, today announced MCP Gateway, a Model Context Protocol (MCP) gateway for kgateway, the ecosystem’s most …

Arialief: We Tested It—Here’s Our Honest Arialief Review “Shocking Conclusion”

Arialief: We Tested It—Here’s Our Honest Arialief Review “Shocking Conclusion”

AURORA, Colo., April 03, 2025 (GLOBE NEWSWIRE) -- Arialief caught my attention from the very first day I heard about it. It’s not every day I commit to testing a new supplement for over three months and then share my personal journey. As someone who has …

big xyt Announces Formal Bid for European Consolidated Tape Provider with Widespread Industry Support

big xyt Announces Formal Bid for European Consolidated Tape Provider with Widespread Industry Support

London, April 03, 2025 (GLOBE NEWSWIRE) -- big xyt, a leading independent provider of high-quality European trade data and analytics, today announced its formal intent to become the official provider of the EU Consolidated Tape (CT) for equities and ETFs. …

Boehringer Ingelheim strengthens antibody-drug conjugate portfolio with new NBE Therapeutics R&D center in Basel

Boehringer Ingelheim strengthens antibody-drug conjugate portfolio with new NBE Therapeutics R&D center in Basel

CHF 27 million investment significantly bolsters Boehringer's ADC portfolio, driven by its subsidiary, NBE Therapeutics, to achieve the company’s aim of transforming the lives of people with cancer.  Basel, Switzerland, Thursday, 03.04.2025 – Today NBE …

LIfT BioSciences gains access to half a million allogeneic donors through collaboration with Gift of Life Biologics

LIfT BioSciences gains access to half a million allogeneic donors through collaboration with Gift of Life Biologics

Press release LIfT BioSciences gains access to half a million allogeneic donors through collaboration with Gift of Life Biologics Access to extensive donor pool supports LIfT’s move into the clinic London, 03 April 2025 – LIfT BioSciences, (‘LIfT’ or ‘the …

Ti5ROBOT stellt auf der HANNOVER MESSE 2025 neue Humanoide vor

Ti5ROBOT stellt auf der HANNOVER MESSE 2025 neue Humanoide vor

HANNOVER, Deutschland, April 03, 2025 (GLOBE NEWSWIRE) -- Die weltberühmte HANNOVER MESSE 2025 findet vom 31. März bis 4. April 2025 statt. In Deutschland treffen sich die Top-Industriegiganten, darunter der aufstrebende chinesische Star Ti5ROBOT aus …

Press Release: Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines

Press Release: Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines

Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines Designation granted for warm autoimmune hemolytic anemia and IgG4-related disease Rilzabrutinib is currently under regulatory review in the US, EU and …

Communiqué de presse : Le rilzabrutinib obtient la désignation de médicament orphelin aux États-Unis pour le traitement de deux maladies rares contre lesquelles il n’existe aucun médicament approuvé

Communiqué de presse : Le rilzabrutinib obtient la désignation de médicament orphelin aux États-Unis pour le traitement de deux maladies rares contre lesquelles il n’existe aucun médicament approuvé

Le rilzabrutinib obtient la désignation de médicament orphelin aux États-Unis pour le traitement de deux maladies rares contre lesquelles il n’existe aucun médicament approuvé Désignation accordée pour l’anémie hémolytique à anticorps chauds et la maladie …

Veteran Banker Joins Avextra’s Supervisory Board 

Veteran Banker Joins Avextra’s Supervisory Board 

    News Release  Dr. Stefan Jentzsch, Partner at the global investment firm Perella Weinberg Partners has been appointed to Avextra’s Supervisory Board, bringing decades of experience in corporate finance, M…

FibroBiologics gibt wissenschaftlicher Fortschritte bei der Reparatur von Hirngewebe bekannt

FibroBiologics gibt wissenschaftlicher Fortschritte bei der Reparatur von Hirngewebe bekannt

HOUSTON, April 03, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (im Folgenden kurz „FibroBiologics“), ein im klinischen Stadium tätiges Biotechnologieunternehmen mit über 240 erteilten und angemeldeten Patenten für die Entwicklung von …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service